Abstract
New research on Artificial Intelligence is the subject of a report. According to news originating from Heidelberg, Germany, by NewsRx correspondents, research stated, “The development of artificial intelligence (AI)-based melanoma classifiers typically calls for large, centralized datasets, requiring hospitals to give away their patient data, which raises serious privacy concerns. To address this concern, decentralized federated learning has been proposed, where classifier development is distributed across hospitals.”
NETL
NSTL
Amer Medical Assoc